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Abstract
Dysferlin is a type II transmembrane protein implicated in surface membrane repair in muscle. Mutations in dysferlin lead to
limbgirdlemusculardystrophy2B,MiyoshiMyopathyanddistalanteriorcompartmentmyopathy.Dysferlin’smodeofactionis
not well understood and only a few protein binding partners have thus far been identified. Using affinity purification followed
by liquid chromatography/mass spectrometry, we identified alpha-tubulin as a novel binding partner for dysferlin. The
association between dysferlin and alpha-tubulin, as well as between dysferlin and microtubules, was confirmed in vitro by
glutathione S-transferase pulldown and microtubule binding assays. These interactions were confirmed in vivo by co-
immunoprecipitation. Confocal microscopy revealed that dysferlin and alpha-tubulin co-localized in the perinuclear region
and in vesicular structures in myoblasts, and along thin longitudinal structures reminiscent of microtubules in myotubes. We
mapped dysferlin’s alpha-tubulin-binding region to its C2A and C2B domains. Modulation of calcium levels did not affect
dysferlin binding to alpha-tubulin, suggesting that this interaction is calcium-independent. Our studies identified a new
binding partner for dysferlin and suggest a role for microtubules in dysferlin trafficking to the sarcolemma.
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Introduction
Mutations in dysferlin cause limb girdle muscular dystrophy 2B
(LGMD2B) [1], Miyoshi Myopathy (MM) [2] and distal anterior
compartment myopathy [3]. Dysferlin is a large type II transmem-
brane protein composed of seven C2 domains and two Dysf domains
[4]. The protein is predominantly expressed in skeletal and cardiac
muscles and has also been reported to be expressed in the placenta [5].
Dysferlin is found in the sarcolemma and the t-tubular system of
muscle fibres and was co-purified with the dihydropyridine receptor, a
membrane protein present in the t-tubule structure [6]. Dysferlin was
also shown to interact, via immunoprecipitation studies, with several
cytosolic and membrane-associated proteins, such as MG53, affixin,
annexins A1 and A2, AHNAK, caveolin-3 and calpain-3
[7,8,9,10,11,12]. Dysferlin, annex i nA 1a sw e l la sm - a n dm u - c a l p a i n s ,
but not calpain-3, were shown independently to participate in
membrane resealing, suggesting that these proteins could work
synergistically to promote Ca
2+-dependent membrane fusion and
actin remodelling near the disruption site [13,14,15,16]. Sarcolemmal
repair is thought to occur by membrane patch formation through the
fusion of subsarcolemmal vesicles located in proximity to the disruption
site [13]. The source of these vesicles is still under debate but may
implicate lysosome-derived vesicles and/or enlargeosomes, a new type
of cytoplasmic vesicles that undergo rapid calcium-dependent, tetanus
toxin insensitive exocytosis, and harbor as a luminal marker the
dysferlin binding protein AHNAK [9,17]. Caveolin-3 was shown to be
implicated in the trafficking of dysferlin to the plasma membrane and
to regulate the endocytosis of dysferlin [18].
We set out to identify additional dysferlin binding partners.
Using affinity purification combined with liquid chromatography/
mass spectrometry (LC-MS/MS), we identified alpha-tubulin as a
novel binding partner for dysferlin in mouse skeletal muscle.
Alpha- and beta-tubulin are the most common members of the
tubulin family. Heterodimers composed of alpha- and beta-tubulin
are needed for the polymerization of microtubules. Microtubules
are dynamic structures that undergo continuous assembly/
disassembly and are implicated in cellular motility, intracellular
transport, mitosis and in the determination of cell morphology.
During the differentiation of myoblasts, the microtubules are
reorganised [19]. In myoblasts, microtubules nucleate at the
centrosome and project towards the plasma membrane. In mature
skeletal muscle cells, microtubules adopt longitudinal structures
that run parallel to the sarcolemma [19,20].
In this study, we sought to characterize the interaction between
dysferlin and alpha-tubulin in muscle cells and tissues. The
interaction detected by LC-MS/MS was further characterized by
co-immunoprecipitation assays using recombinant or native
proteins, as well as by direct binding assays with purified proteins
and by confocal microscopy.
Materials and Methods
Ethics Statement
All animals were handled in strict accordance with good animal
practice as defined by the relevant national and/or local animal
welfare bodies, and all animal work was approved by the
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Review Board of the Montreal Neurological Institute, McGill
University, Montreal, Canada.
Cells, Animals, Plasmids and Antibodies
The human embryonic kidney-derived cell line, HEK293T, and
the mouse myoblast-derived cell line, C2C12, were purchased
from ATCC (Burlington, Ontario; ATCC number CRL-1573 and
CRL-1772, respectively). CD1 mice were purchased from Charles
River (Montreal, Canada).
The GFP-His-myc tagged dysferlin cDNA cloned into DSC-B
plasmid was kindly provided by Dr K. Bushby (Newcastle, U.K)
[21]. In this construct, the GFP coding sequence is located at the
59 end, and the His-myc tags are located at the 39 end of the
dysferlin cDNA. For the experiments in which only His-myc-
dysferlin was used, the GFP tag was removed by EcoRI/NotI
restriction enzyme digestion.
The TubA4A and TubA1B constructs were generated from
commercially available cDNA clones in pCMV6-XL5 vector
(Origene). EcoRI and NotI restriction sites were included in the
primer sequence to facilitate subcloning of the PCR fragment into
pGEX4T1 (GE Healthcare) in order to generate GST fusion
proteins.
The cloning of the GST recombinant dysferlin C2 domains was
described previously [22]. All of the GST fusion proteins were
expressed in E.coli BL21 and purified with glutathione-Sepharose
4B beads according to the manufacturer’s instructions (Amersham
Biosciences) and kept at 4uC until needed.
Monoclonal antibodies against c-myc, dysferlin, alpha-tubulin
and GFP were purchased from the following suppliers, respec-
tively: Biomol International, Vector laboratories, Invitrogen and
Roche Diagnostics. For the detection of GST, we used goat
polyclonal antibodies from GE Healthcare. Goat anti-rabbit IgG-
HRP conjugate was purchased from Invitrogen and Cy
TM3-
conjugated AffiniPure goat anti-mouse IgG antibody was
purchased from Jackson Immunoresearch laboratories.
Co-immunoprecipitation and Pulldown Assays
Transfected HEK293T cells grown in 100-mm dishes were
washed with PBS and resuspended in 1 ml/dish with buffer A
(10 mM HEPES, pH 7.4, protease inhibitors (Roche complete
cocktail)). The cells were sonicated and Triton X-100 was added to
a final concentration of 1%. Protein extracts were incubated for
20 min at 4uC and centrifuged at 13,000 rpm. For co-immuno-
precipitation assays, extracts of transfected cells were precleared
with protein A-Sepharose beads. The precleared supernatants
were then incubated with the indicated antibodies and protein A-
Sepharose beads for 16 h at 4uC. Beads were washed extensively
with buffer A with 1% Triton X-100 and prepared for Western
blot analysis by resuspension in 50 ml of buffer containing 2%SDS,
0.5% b-mercaptoethanol and 2% glycerol and heating to 95uC for
5 minutes prior to loading on a 3%–12% polyacrylamide gradient
SDS-page gel.
For dysferlin C2 domain GST pulldown assays, C2 domain
sequences were cloned into pGEX4T1 vectors, expressed in E. coli
BL21 and purified by affinity chromatography with glutathione
Sepharose 4B beads, as described in [22]. C2C12 myoblasts were
lysed in a buffer containing 10 mM HEPES, pH 7.4, 33 mM
NaCl and protease inhibitors (10 mM aprotinin, 10 mM leupeptin,
1 mM benzamidine, 1 mM PMSF, 1 mM E-64). After centrifuga-
tion at 13,000 rpm, 1 mg of C2C12 lysate was incubated
overnight at 4uC with 10 mg of each GST-C2 domain fusion
protein immobilized on glutathione Sepharose 4B beads, in the
presence of 1 mM CaCl2 or 1 mM EGTA. The beads were
washed extensively in the same buffer and prepared for Western
blotting.
For the GST-TubA4A and GST-TubA1B pulldown assay and
the calcium titration assay, dissected leg muscles from 4 week old
mice were homogenized in a buffer containing 50 mM HEPES
pH 7.6, 150 mM NaCl, 20 mM pyrophosphate sodium, 10 mM
NaF, 2 mM sodium orthovanadate, 1% Triton X-100, 10%
glycerol, 1 mM MgCl2 and protease inhibitor cocktail (Roche).
After centrifugation at 100,0006g, 1 mg of protein was incubated
overnight at 4uC with 10 mg of each GST-TubA fusion-protein
isoform immobilized on glutathione Sepharose 4B beads. The
beads were washed extensively in the same buffer and prepared for
Western blotting. For the calcium titration assay, 1 mg of protein
extracts were immunoprecipitated with protein A-Sepharose
coupled to anti-alpha-tubulin antibody in presence of 1 mM of
EGTA or increasing concentration of calcium. For this experi-
ment, EDTA in the lysis buffer was compensated by adding a
neutralizing amount of calcium, with subsequent calcium titration.
The beads were washed extensively in the same buffer and
prepared for Western blotting.
Purification of His-myc-dysferlin
His-myc-dysferlin was overexpressed in HEK293T cells,
captured on Ni-NTA beads using buffer A with 20 mM imidazole.
Beads were washed in PBS buffer containing 50 mM imidazole,
and His-myc-dysferlin was then eluted with 400 mM imidazole.
The buffer was exchanged with 10 mM HEPES buffer pH 7.4
plus protease inhibitors using an Amicom Ultra centrifugal filter
device (Millipore) in order to remove the imidazole, which is
known to depolymerize microtubules [23].
Western Blot
The membrane was blocked for 1 hour in buffer containing
PBS-T (0.1% Tween-20) + 5% milk then incubated 16 h with the
appropriate antibody (1:1000) in the same buffer. The membrane
was washed with the same buffer then incubated 1 hour with anti-
mouse or anti-rabbit IgG HRP-conjugated antibody in the same
buffer (1:1000 dilution). The membrane was washed in PBS and
detected by Amersham Hyperfilm ECL (GE Healthcare).
Liquid Chromatography- Mass spectrometry (LC-MS/MS)
We used the service of the IRCM (Institut de recherches
cliniques de Montre ´al) for the LC-MS/MS analysis. The method
used for the LC-MS/MS analysis was described in detail in [24].
Briefly, the entire SDS-PAGE gel lane of co-purified dysferlin
binding partners as well as its control lane were each excised into
14 bands and then cut into 1 mm
3 pieces. Minced gel pieces were
destained in 100 mM sodium thiosulfate and 30 mM potassium
ferricyanide for 15 min, followed by a 5 min wash with 50 mM
ammonium bicarbonate. Gel pieces were dehydrated with
acetonitrile, reduced with a buffer containing 10 mM dithiothre-
itol and 100 mM ammonium bicarbonate for 30 min at 40uC, and
then alkylated with a buffer containing 55 mM iodoacetamide and
100 mM ammonium bicarbonate for 20 min at 40uC. Gel pieces
were dehydrated and washed at 40uC by adding acetonitrile for
5 min. Gel pieces were dried for 5 min at 40uC and then re-
hydrated at 4uC for 40 min with the trypsin solution (6 ng/mlo f
sequence grade trypsin in 25 mM ammonium bicarbonate).
Proteins were digested at 58uC for 1 h. Peptides were extracted
with a buffer containing 1% formic acid and 50% acetonitrile.
Peptide extracts were loaded on a LC column, which was a 75 mm
ID fused silica capillary of 100 mm length packed with the Jupiter
5 mm C18 300 A ˚ reverse-phase material (Phenomenex). This
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coupled to the LTQ Orbitrap (ThermoFisher Scientific).
The mass resolution for MS was set to 30,000 (at m/z 400).
Protein database searching was performed with Mascot 2.1
(Matrix Science) against the human NCBInr protein database.
Microtubule Binding Assay
His-myc-dysferlin was prepared as described above. The
microtubule binding assay was performed according to the
manufacturer’s instructions (Cytoskeleton, microtubule binding
protein spin-down assay kit, Cat.# BK029). Briefly, MTs were
prepared from 100 mg of tubulin monomers in 20 ml of PEM
containing 1 mM GTP and 5% glycerol at 35uC for 20 min and
immediately stabilized in 200 ml of PEM-20 mM Taxol. The MTs
(4 mM tubulin) were incubated with 3 mg of purified His-myc-
dysferlin for 30 minutes at room temperature in a reaction volume
of 50 ml. The reaction mixtures were then centrifuged at
100,0006g at 25uC for 15 min in the presence of a 50% glycerol
cushion-PEM-Taxol gradient. Proteins in the supernatant and
pellet were separated on a 5–16% gradient polyacrylamide gel and
visualized by Coomassie blue staining. BSA was used as a negative
control and the microtubule binding fraction (MAPF) provided by
the cytoskeleton assay kit containing MAP2A, MAP2B, MAP1 and
tau as a positive control, where MAP2 constitutes 70% of MAPF.
Immunofluorescence
C2C12 myoblasts were seeded on poly-D-lysine-coated cover-
slips and transfected with GFP-dysferlin using Lipofectamine 2000
(Invitrogen) and incubated for 16 h. Myotube formation was
induced by switching the cells to DMEM media plus 5% horse
serum (Gibco) for 5 days [25]. Cells were fixed with 4%
paraformaldehyde in PBS for 4 minutes, permeabilized with
0.2% Triton X-100 in PBS for 4 minutes, blocked with 0.4% BSA
and stained with anti-tubulin monoclonal antibody for 1 hour and
finally incubated with Cy
TM3-conjugated AffiniPure goat anti-
mouse IgG antibody. Images were captured on Zeiss LSM 710
inverted confocal microscopy using the Zen 2008 image analysis
system.
Results
Identification of alpha-tubulin as a novel dysferlin protein
interactor
To identify dysferlin binding partners, we carried out Liquid
chromatography-Mass spectrometry (LC-MS/MS) analysis on
proteins obtained by pulldown with His-myc-dysferlin from mouse
skeletal muscle homogenate (Figure 1). His-myc-dysferlin was
overexpressed in HEK293T cells and purified by affinity from the
cell lysates using protein A-Sepharose beads coated with anti-myc
monoclonal antibodies. Beads were extensively washed and
incubated with mouse skeletal muscle homogenate. Extract from
non-transfected HEK293T cells was used as a negative control;
since these cells do not express any detectable amounts of dysferlin
(Fig. 2A, lower panel). After extensive washing, affinity-purified
complexes were separated by SDS-PAGE and visualized by silver
staining (Fig. 2B). The entire gel lane for both the control and the
pulldown were each excised into 14 bands, and each band was cut
into 1 mm
3 pieces which underwent subsequent in-gel trypsin
digestion. The resulting peptides were separated and analyzed
with a nanoscale liquid chromatography quadrupole time of flight
Figure 1. Schematic representation of the proteomic analysis
by mass spectrometry. The procedure includes overexpression of
His-myc-dysferlin in HEK293T cells, purification on protein A-Sepharose
beads coupled to anti-myc antibody, incubation of the myc-dysferlin
beads with mouse skeletal muscle homogenate and the identification
of the co-purified proteins using LC-MS/MS.
doi:10.1371/journal.pone.0010122.g001
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[24]. Protein database searching was performed with Mascot 2.1
(Matrix Science) against the human NCBInr protein database.
The experiment was repeated twice and proteins found in both
control and pulldown were discarded as false positives.
We identified proteins originating from both HEK293T cells
(identified by LC-MS/MS as being of human origin) as well as
from mouse skeletal muscle (identified by LC-MS/MS as
originating from mouse species) that showed significant association
with dysferlin, and we focused on those proteins originating from
mouse muscle. Importantly, we were able to identify the few
proteins previously reported to interact with dysferlin, such as
caveolin-3, affixin, AHNAK, annexin A1 and annexin A2 as well
as calpain-3 (Fig. 2B), thus validating our approach as being able
to detect dysferlin interacting partners. The newly identified
proteins revealed in our analysis fall into several categories: surface
membrane proteins, proteins involved in cellular trafficking,
regulatory proteins and proteins related to the ubiquitin system.
A 55 kDa band was found in the pulldown assay and contained 44
peptides matching to alpha-tubulin (Fig. 2B). Knowing that
microtubules are used as trafficking pathway by the majority of
the proteins that are targeted to the plasma membrane, we sought
to study the interaction between dysferlin and alpha-tubulin.
Alpha-tubulin binds to dysferlin in muscle cells
In order to confirm the interaction between alpha-tubulin and
dysferlin found through the LC-MS/MS analysis, we undertook a
series of protein binding and co-immunoprecipitation studies using
recombinant and native proteins. Using immobilized recombinant
GST-tubulin, we were able to detect binding interactions through
the capture of endogenous dysferlin from mouse skeletal muscle
(Fig. 3A). Interestingly, both isoforms of alpha-tubulin were able to
capture murine dysferlin. TubA4A is expressed mainly in the testis
and TubA1B is ubiquitous.
The interaction between dysferlin and alpha-tubulin in cells was
addressed using a heterologous system. GFP-dysferlin was
expressed in HEK293T cells and used for immunoprecipitation
with anti-GFP antibodies. Native alpha-tubulin was found to co-
immunoprecipitate with recombinant GFP-dysferlin (Fig. 3B). To
account for any putative artefacts caused by an overexpression
system, we next performed immunoprecipitation assays using
C2C12 myotubes or mouse skeletal muscle homogenate with anti-
alpha-tubulin antibodies. Native dysferlin co-immunoprecipitated
with alpha-tubulin in muscle cells or tissues (Fig. 3C, Fig. 3D). A
faint band is present in the control lane of Fig. 3C which we
consider non-significant. Taken together, these results suggest that
dysferlin interacts with alpha-tubulin in vitro as well as in vivo.
Alpha-tubulin interacts with dysferlin’s C2A and C2B
domains in a calcium-independent manner
Since dysferlin is a multi-domain protein, we sought to identify
which of dysferlin’s seven C2 domains are involved in the
interaction with alpha-tubulin (Fig. 4A). Recombinant GST-
dysferlin C2 domain fusion proteins were immobilized on
glutathione-Sepharose 4B beads and were incubated with
C2C12 myoblast extract. Dysferlin-bound alpha-tubulin was
detected by Western blotting with anti-alpha-tubulin antibodies.
Alpha-tubulin was able to bind only to the C2A and C2B domains
of dysferlin, while the other C2 domains did not bind to alpha-
tubulin (Fig. 4B). The absence of alpha-tubulin binding to the
GST moiety alone indicated that the binding to the dysferlin C2
domains A and B was specific.
Dysferlin C2 domains contain acidic residues in their Ca
2+-
binding loops, suggesting that their interactions with lipids and
proteins could be modified by cations. We showed previously that
the C2A domain of dysferlin is the only Ca
2+-dependent lipid
binding C2 domain that might be important for calcium-
dependent membrane interactions in muscle [22]. We therefore
Figure 2. Alpha-tubulin is identified as a dysferlin interacting protein through affinity purification and mass spectrometry analysis.
A. Western blot to detect the expression of His-myc-dysferlin in transfected HEK293T cells (top panel), the immunoprecipitated myc-dysferlin (middle
panel) and expression of endogenous dysferlin in mouse skeletal muscle homogenate (bottom panel). B. SDS-PAGE resolution of the co-purified
dysferlin partner stained with silver nitrate. Left lane is the control, whereby His-myc-dysferlin was not transfected into HEK293T cells. Right lane is the
immunoprecipitate with myc-dysferlin. Bands containing alpha-tubulin and previously described dysferlin binding partners are highlighted. IB:
Immunoblot, IP: Immunoprecipitation, CTL: control.
doi:10.1371/journal.pone.0010122.g002
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2+ on the interaction between
dysferlin C2 domains and alpha-tubulin. The interaction with the
C2A and C2B domains of dysferlin both demonstrated calcium-
independent binding activity. No binding was found with the other
dysferlin C2 domains in either the presence or absence of Ca
2+
(Fig. 5A). Since the conformation of these individual domains
could be altered under physiological conditions, we evaluated the
possibility that these binding interactions could be different in
muscle expressing full-length dysferlin. We performed a Ca
2+
titration experiment for the binding interaction of alpha-tubulin
and dysferlin in mouse muscle tissue. Analysis of the co-
immunoprecipitates revealed that Ca
2+ was not required for
alpha-tubulin binding by native dysferlin in mouse muscle tissue
(Fig. 5B).
Dysferlin interacts with microtubules
Alpha-tubulin exists in cells as soluble monomers or as soluble
heterodimers together with beta-tubulin. The tubulin heterodi-
mers serve as building blocks for the growing polymers of
microtubules in cells. Hence, we examined whether dysferlin
could bind to microtubules by using an in vitro microtubule
sedimentation assay. Recombinant His-myc-dysferlin was incu-
bated with polymerized microtubules. BSA was used as a negative
control and MAPF (microtuble binding fraction) containing
MAP2A, MAP2B, MAP1 and tau as a positive control, where
MAP2 constitutes 70% of MAPF. His-myc-dysferlin and MAPF
proteins were found to pellet with microtubules, whereas BSA did
not (Fig. 6). In addition, both dysferlin and MAPF did not pellet in
the absence of microtubules and remained in the soluble fraction.
To further confirm this molecular interaction, we examined
the cellular distribution of dysferlin and microtubules in C2C12
myoblasts and myotubes. We transiently transfected C2C12
myoblasts with GFP-dysferlin and induced myotube formation.
Cells were fixed and stained for alpha-tubulin (Fig. 7). The
staining pattern of alpha-tubulin differed in myoblasts from the
pattern seen in myotubes. In the former, we observed the typical
mesh-like distribution of microtubules in the cytoplasm, which
originates from a microtubule organizing center near the nucleus.
Figure 3. Dysferlin complexes with alpha-tubulin. A. GST, GST-TubA4A and GST-TubA1B fusion proteins immobilized onto glutathione-
Sepharose 4B beads were incubated with mouse skeletal muscle homogenate. GST, GST-TubA4A or GST-TubA1B with adsorbed proteins from mouse
skeletal muscle were resolved by SDS-PAGE, transferred onto a nitrocellulose membrane, and blotted with mouse monoclonal anti-dysferlin antibody.
Left panel: nitrocellulose membrane stained with ponceau red, right panel: detection of immunoreactive dysferlin. B. GFP-dysferlin was
overexpressed in HEK293T cells and then immunoprecipitated from cell extracts with anti-GFP antibody. As a control, protein A-Sepharose beads
coated with anti-GFP antibody were incubated with extracts of non-transfected HEK293T cells. Proteins were separated on SDS-PAGE gel and were
transferred onto a nitrocellulose membrane and blotted with anti-GFP or anti-alpha-tubulin antibodies. Input (right panel), immunoprecipitate (left
panel). C–D. Co-immunoprecipitation of dysferlin with anti-alpha-tubulin antibody from C2C12 myotube extracts (C) or mouse skeletal muscle
homogenate (D). Input (right panel), immunoprecipitate (left panel). As a control (CTL), protein A-Sepharose beads were incubated with myotube
extracts in the absence of anti-alpha-tubulin antibody.
doi:10.1371/journal.pone.0010122.g003
Dysferlin Proteomic Analysis
PLoS ONE | www.plosone.org 5 April 2010 | Volume 5 | Issue 4 | e10122In myotubes, this pattern is changed and adopts a longitudinal
configuration along the myotube axis. In myoblasts, GFP-
dysferlin was found to partially co-localize with alpha-tubulin in
the perinuclear region, as well as in vesicular structures (Fig. 7A).
In myotubes, GFP-dysferlin partially co-localized with alpha-
tubulin in thin longitudinal structures indicative of microtubules
(Fig. 7B).
Discussion
Dysferlin is a multi-domain transmembrane protein implicated
in skeletal muscle surface membrane repair. The function of
dysferlin in membrane repair is supported by several lines of
evidence obtained through the study of dysferlinopathic animal
models [12,13,26,27], as well as through the molecular charac-
terization of dysferlin’s protein and lipid binding partners
[6,7,8,9,12,13,22]. Several muscle proteins were shown to interact
with dysferlin, such as MG53, affixin, annexins A1 and A2,
caveolin-3, calpain-3, the dihydropyridine receptor and AHNAK
in mouse or human skeletal muscle [6,8,9,10,12,28]. Some of these
proteins were also shown to be implicated in the repair of
membrane tears of muscle fibres like annexins which are fusogenic
proteins with affinity for membrane lipids and phosphoinositides
[14,29] or MG53, a protein implicated in vesicular trafficking
[12]. Thus, the concept of a protein repair complex is emerging
and probably involves several other proteins and lipid compo-
nents. The role of dysferlin as a Ca
2+ sensor is well accepted and
similarly to otoferlin, a Ca
2+ sensor of the inner ear hair cell ribbon
synapse, may promote vesicle fusion to the plasma membrane in
skeletal muscle fibres [30]. The discovery of other dysferlin
molecular interactors will undoubtedly be useful in the under-
standing of dysferlin biology.
Figure 4. Alpha-tubulin interacts with dysferlin through the C2A and C2B domains. A. Schematic illustration of full-length wild type
dysferlin and the various GST-C2 domain constructs used. B. C2C12 myoblast extract was incubated with GST alone or with the various GST-C2
domains precoupled to glutathione-Sepharose 4B beads. The bound proteins were separated on SDS-PAGE followed by Western blot analysis using
anti-alpha-tubulin antibody. SM: standard material. Lower panel: nitrocellulose membrane of GST-dysferlin C2 domains with adsorbed proteins from
the cell extract stained with ponceau red.
doi:10.1371/journal.pone.0010122.g004
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dysferlin protein binding partners through the analysis of
immunoprecipitated proteins from mouse skeletal muscle using
Liquid chromatography-Mass spectrometry (LC-MS/MS). We
identified alpha-tubulin as a novel dysferlin binding protein and
showed that it interacts with dysferlin through the C2A and C2B
Figure 5. Alpha-tubulin interacts with dysferlin in a calcium-independent manner. A. Upper panel: Myoblast cell extracts were incubated
with GST alone or the various GST-dysferlin C2 domain fusion proteins precoupled to glutathione-Sepharose 4B beads in the absence (2) or presence
(+) of 1 mM calcium. The bound proteins were separated on SDS-PAGE followed by Western blot analysis using anti-alpha-tubulin antibody. Lower
panel: nitrocellulose membrane of GST-dysferlin C2 domains with adsorbed proteins from the cell extract stained with ponceau red. B. Co-
immunoprecipitation of alpha-tubulin and dysferlin with anti-alpha-tubulin antibody from mouse skeletal muscle homogenate in the presence of
increasing calcium concentrations. Proteins were separated and detected with anti-alpha-tubulin and anti-dysferlin antibodies. As a control (CTL),
protein A-Sepharose beads were incubated with muscle homogenate in the absence of anti-alpha-tubulin antibody.
doi:10.1371/journal.pone.0010122.g005
Figure 6. Dysferlin binds to microtubules. His-myc-dysferlin purified on Ni-NTA beads was incubated with polymerized microtubules. Reactions
were resolved by SDS-PAGE stained with SimplyBlue SafeStain. Arrows point to His-myc-dysferlin, tubulin, BSA, and to MAP1&MAP2 of the
microtubule-associated protein fraction (MAPF), which includes MAP2A, MAP2B, MAP1 and tau. S: Soluble phase, P: Pellet. Lane 1: Microtubules alone,
lane 2: Microtubules incubated with MAPF, lane 3: Microtubules incubated with BSA, lane 4: MAPF alone, lane 5: BSA alone, lane 6: Purified His-myc-
dysferlin alone, lane 7: Microtubules incubated with purified His-myc-dysferlin.
doi:10.1371/journal.pone.0010122.g006
Dysferlin Proteomic Analysis
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that dysferlin was able to bind to polymerized tubulin in form of
microtubules in vitro and in vivo.
Microtubules are involved in maintenance of cell morphology,
distribution and transport of membrane proteins, cell polarization
and motility. Molecular details of these processes are still under
investigation; however, a novel class of microtubule plus-end-
binding proteins shed new light on transport between the
endoplasmic reticulum (ER), Golgi apparatus and the plasma
membrane. Experiments using mammalian epithelial cell lines
have elucidated biosynthetic and recycling pathways for apical and
basolateral plasma membrane proteins, and have identified
components that guide apical and basolateral proteins along these
pathways [31,32]. Recent live-cell-imaging studies provide a real-
time view of sorting processes in epithelial cells, including key roles
for microtubules in protein transport to the plasma membrane
[33,34]. In this regard it is interesting that our study identified
dysferlin as a microtubule binding protein, since dysferlin has to be
transported to the surface plasma membrane of muscle cells.
We demonstrated that dysferlin co-localizes with microtubules
in myoblasts as well as in myotubes, and we believe that this
interaction is of significance despite the fact that the observed co-
localization is only partial.
Another protein shown to interact, yet to only partially co-
localize with microtubules is Annexin XI. Partial co-localization
with microtubules was shown for Annexin XI in human
epidermoid cancer cells (HEp-2) [35]. Annexins, like C2-domain
proteins, are Ca
2+ effector proteins that bind to negatively-charged
phospholipids and provide a link between calcium signalling and
membrane functions [36].
The trafficking of normal or mutant ferlin proteins in
mammalian cells is under-characterized and only partial traffick-
ing data is available. For example, endocytosed myoferlin is
recycled back to the plasma membrane via the EHD2 protein, a
carboxyl-terminal EH domain-containing protein implicated in
surface membrane protein recycling [37]. An EHD2 mutant
expressed in myoblasts led to the sequestration of myoferlin in
recycling endosomes and inhibition of myoblast fusion [37].
Caveolin-3 maintains a plasma membrane pool of dysferlin by
inhibiting dysferlin endocytosis through a clathrin-independent
pathway [38]. The plasma membrane localization of dysferlin
implies that it is translocated and inserted into the ER membrane
after its synthesis in the cytosol and then targeted to the plasma
membrane by the secretory pathway. Dysferlin localization
remains a subject of argument. Full-length dysferlin was shown
to localize to the T-tubule system and to translocate to the injury
site in C2C12 myotubes [6], whereas other studies showed that
dysferlin is localized to vesicles near the Golgi apparatus [21]. The
trans-Golgi sorting mechanism and the type of vesicles used by
dysferlin to reach the plasma membrane are not known.
Recently, MG53 was shown to interact with dysferlin and
caveolin-3 to facilitate vesicle trafficking to the site of membrane
injury and to mediate the movement of dysferlin to the site of
injury [12].
It was previously shown that the C2A domain of dysferlin
bound phosphoinositides and phosphatidylserine in a Ca
2+-
dependent fashion [22]. Dysferlin’s C2A domain shares structural
homology with the C2A domain of synaptotagmin I, which also
binds similar phospholipids [39,40]. Synaptotagmins play an
essential role in neurotransmitter release by acting as a calcium
sensor mediating calcium-dependent synaptic vesicle exocytosis
[41,42]. It was shown that tubulin interacts directly with both the
C2A and C2B domains of synaptotagmin I [43]. For synapto-
tagmin I, it was suggested that direct tubulin binding provides a
mechanism for retaining synaptic vesicles on microtubules as a
readily releasable pool. Synaptic vesicles in the nerve terminal are
stored in two distinct pools: the readily releasable pool, which is
kept close to the active zone, and the reserve pool, which is stored
at a distance from the plasma membrane [44,45]. In another
paradigm, in experiments performed in PtK2 (rat kangaroo
kidney) cells, it has been shown that following membrane
disruption, microtubule rearrangement occurs towards the site of
injury [46]. Unifying these and our observations, we hypothesize
that dysferlin is stored in a ready pool close to the cell surface
through its interaction with microtubules. This interaction could
be essential to ensure a ready pool of dysferlin required for
membrane resealing.
We demonstrate that dysferlin’s interaction with alpha-tubulin is
mediated by the C2A and C2B domains in a calcium-independent
manner. This is at odds with the described calcium-dependent
phospholipid binding of dysferlin’s C2A domain [22] and with the
described calcium-dependent binding of synaptotagmin I to
microtubules [43]. However, synaptotagmin IX was recently
reported to bind alpha- and beta-tubulin in the absence of calcium
in rat basophilic leukemia mast cells (RBL) [47], which is in line
with our findings. Binding of synaptotagmin IX to beta-tubulin,
but not to alpha-tubulin, was enhanced only at very high, non-
physiological concentrations of Ca
2+ in that study [47].
In conclusion, we have identified alpha-tubulin as a novel
protein binding partner of dysferlin. Our findings demonstrate that
dysferlin binds to alpha-tubulin through its C2A and C2B domains
as well as to microtubules. It will be of great interest to determine
the implications of this protein interaction on the plasma
membrane homeostasis and on dysferlin trafficking in skeletal
muscle.
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